Catalyst Wire Dossier Catalyst Wire Dossier

UNR844 Chloride (UNR844-Cl) Eye Drops

UNR844-Cl · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UNR844 Chloride (UNR844-Cl) Eye Drops, covering 2020-11-27 to 2020-11-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia. [Phase 2]

See pricing